Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins Medicine investigators report, ...
Apr 17, 2025
0
9